Clinical Trial Update: Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial of low-dose naltrexone for inflammatory bowel disease has been withdrawn. The conditions involved include Crohn's disease and ulcerative colitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Low Dose Naltrexone (naltrexone)

Snippet

Sponsor: Santa Barbara Cottage Hospital | Conditions: Inflammatory Bowel Disease, Crohn's Disease | Phase 2 | Status: WITHDRAWN